Cecile M Yelnik, Marc Lambert, Elodie Drumez, Claire Martin, Gaelle Grolaux, David Launay, Eric Hachulla, Stephanie Rogeau, Sylvain Dubucquoi, Eric Boulanger, Steve Lancel, Marie Frimat
OBJECTIVES: To evaluate whether inflammatory and complement biomarkers are associated with specific characteristics of antiphospholipid syndrome (APS). METHODS: Serum levels of interleukin (IL)-1β (IL-1β), IL-6, IL-8, IL-10, tumour necrosis factor (TNF)-α, interferon-α (IFN)-α, IFN-γ, vascular endothelial growth factor (VEGF), intercellular adhesion molecule 1 (ICAM-1), E-selectin, and vascular cell adhesion molecule (VCAM)-1, and plasma levels of soluble C5b-9 (sC5b-9), C3a, C4a, Bb fragment were measured in unselected APS patients...
June 6, 2023: Clinical and Experimental Rheumatology